Circulating tumor cells (CTCs) are tumor cells that have sloughed off the primary tumor and
extravasate into and circulate in the blood. Understanding of the metastatic cascade of CTCs …

Plasmonic gold nanoparticles have been used increasingly in solid-state systems because
of their applicability in fabricating novel sensors, heterogeneous catalysts, metamaterials …

Simple Summary Circulating tumour cells (CTCs) are cancer cells shed into the bloodstream
from tumours and their analysis can provide important insights into cancer detection and …

Nanoscale materials have unique properties that make them especially useful for
biomedical diagnostic applications. Recent developments in nanoengineering have resulted …

The importance of early cancer diagnosis and improved cancer therapy has been clear for
years and has initiated worldwide research towards new possibilities in the care strategy of …

Detecting cancer biomarkers (eg, circulating tumor cells, extracellular vehicles, nucleic
acids, and protein biomarkers) is vital for risk assessment and early diagnosis. Nanomaterial …

The selection of circulating tumor cells (CTCs) directly from blood as a real-time liquid
biopsy has received increasing attention over the past ten years, and further analysis of …

Circulating tumor cell (CTC)‐enrichment by using aptamers has a number of advantages,
but the issue of compromised binding affinities and stabilities in real samples hinders its …

During cancer progression, many tumours shed circulating tumour cells (CTCs) and other
biomarkers into the bloodstream. The analysis of CTCs offers the prospect of collecting a …

Of late, biosensing is receiving mounting expectations due to a pressing need for swift and
accurate stimulus detection. Sensing via biological moieties has outmoded conventional …